Michael E. Carney, MD, is a Thomas S. Kosasa Endowed professor and division chief in gynecologic oncology at the John A. Burns School of Medicine and University of Hawaii Cancer Center in Honolulu, Hawaii. He specializes in complex and minimally invasive surgery, treating gynecologic cancers with surgery and chemotherapy, in addition to research including clinical, epidemiologic, and genetic investigations for gynecologic cancers. Dr. Carney is the current president of the Hawaii Society of Clinical Oncology.

A graduate of Loyola University Stritch School of Medicine, he completed his residency in obstetrics and gynecology at Duke University. His fellowship was in gynecologic oncology at Duke University.

Shane Morita, MD, MS, PhD, FACS, is the surgical oncology program director at The Queen’s Medical Center/Queen’s Cancer Center and is part of the clinical faculty for the John A. Burns School of Medicine and the University of Hawaii Cancer Center. He is actively involved in program development for the Queen’s multidisciplinary cancer clinic and conducts research centered on molecular pathways and ethnic disparity of cancer in Hawaii, including thyroid carcinoma and cutaneous melanoma.

Additionally, Dr. Morita is the incoming Chair for the State of Hawaii Comprehensive Cancer Control Coalition and an active board member of the American Cancer Society Hawaii-Pacific chapter. He has received numerous awards for his research and was the sole recipient of the NCCTG junior faculty grant from the Mayo Clinic.

Ryon K. Nakasone, MD, is a medical oncologist affiliated with the MD Anderson Cancer Network in Hawaii, largely practicing at the Kapiolani Medical Center for Women & Children, Kuakini Health System, and The Queen's Medical Center.

Kelly Shimabukuro, MD, is a member of several professional organizations, including the American Society of Clinical Oncology and the American Society of Hematology. Additionally, she has a background in HIV malignancies and served as a member of the AIDS Malignancy Consortium. At the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies, Dr. Shimabukuro presented her clinical research on AIDS-associated Kaposi Sarcoma.

Nicolas Alan Villanueva, MD, is a hematology and medical oncology specialist at The Queen’s Health Systems. He is a 2013 graduate of the University of Hawaii John A. Burns School of Medicine. Dr. Villanueva is trained to evaluate and treat a wide range of both solid and hematologic cancers, and benign hematologic conditions. His research interests are in lung cancer, particularly in non-smokers.

Keola K. Beale, MD, is a board-certified hematology and oncology specialist in Honolulu, Hawaii. Dr. Beale was inspired to become an oncologist after losing both his father and grandfather to cancer during his medical training. An avid researcher, he participates in Kaiser Permanente's large oncology clinical trials program. He strives to communicate with his patients in an informative and empathetic manner, treating every patient as he would a loved one.

He received his medical degree at University of California School of Medicine in San Francisco, California.

Susie Chen, MD, is a radiation oncologist affiliated with the Kapiolani Medical Center for Women & Children, Pali Momi Medical Center, and Straub Medical Center. She has extensive training in a variety of radiotherapy types, including low dose rate and high dose rate brachytherapy, nongynecologic brachytherapy, orthovoltage therapy, electron therapy, conventional stimulation, and 4D CT simulation.

Benjamin Falit, MD, JD, is the medical director of the Pacific Cancer Institute and a radiation oncology specialist, in Wailuku, Hawaii. He is trained in the use of novel, more precise radiation delivery techniques, including intensity modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Dr. Falit has published and been an invited speaker on several panels related to health care policy and economics. After residency, Dr. Falit practiced in the greater Boston area as an attending radiation oncologist at Lowell General Hospital and Wentworth Douglass Hospital and joined the Pacific Cancer Institute in 2016. He is also board certified and a diplomat of Radiation Oncology by the American Board of Radiology. 

Dr. Falit received a BA in Psychology from Brandeis University in Waltham, MA, and medical degree from the Yale School of Medicine at Yale University in New Haven, CT. After completing an internship in internal medicine at Yale New Haven Hospital, he trained at the Harvard Radiation Oncology Program in Boston where he saw patients at Massachusetts General Hospital, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital.

Charles F. Miller, MD, FACP, FASCO, is board certified in medical oncology, hematology, and internal medicine and is a Fellow of the American College of Physicians. He served for 30 years in the US Army Medical Department, serving as Commander, 3rd Combat Support Hospital, Nuremberg, Germany and completing his service as the Chief Consultant to the US Army Surgeon General. After retiring from active duty, he completed 9 years as Chief of Hematology-Oncology at Kaiser Medical Center, Honolulu, Hawaii. He has served on the Hawaii Society of Clinical Oncology Board of Directors since 2002 and served as President for seven of those years. He is actively involved at the national level with the American Society of Clinical Oncology, having served on the Clinical Practice Committee, Government Relations Committee, State Affiliate Council, currently serving as Chair, and has actively participated in all ASCO’s Advocacy Summits. He holds a clinical appointment at the University of Hawaii Cancer Center. He has been an active supporter of patient choice for end-of-life care for the people of the state of Hawaii as a member of Doctors for Dignity.

Dr. Miller received his medical degree from the University of Southern California School of Medicine, Los Angeles, California. He completed his residency training at Tripler Army Medical Center Honolulu, Hawaii and fellowship in Hematology-Oncology at Walter Reed Army Medical Center, Washington, DC.

David Tamura, MD, is a credentialed provider with MD Anderson Cancer Network, providing clinical care at The Queen's Medical Center in Hawaii. His areas of expertise include hematologic, gastrointestinal, and genitourinary malignancies. In addition to his clinical practice, he educates students and house staff from the University of Hawaii John A. Burns School of Medicine, and is actively involved in clinical research at the University of Hawaii Cancer Center.

Dr. Stephanie Si Lim, MD, is an assistant researcher in pediatric oncology at University of Hawaii Cancer Center and an attending physician at Kapi'olani Women's & Children's Hospital in Honolulu, Hawaii. Her overall research goal is to better understand ethnic disparities within the field of immunotherapy and cancer care disparities within the Hawaiian Islands. Clinically, she is also hoping to introduce chimeric antigen receptor (CAR) T-cell therapy to patients, with the goal of providing the best cancer care to residents of Hawaii.

She graduated from Georgetown University School of Medicine and completed both her residency and fellowship training at the Children's Hospital of Philadelphia.